Literature DB >> 6185616

Immune response to a thymus-dependent form of B512 dextran requires the presence of Lyb-5+ lymphocytes.

K E Stein, D A Zopf, C B Miller, B M Johnson, P K Mongini, A Ahmed, W E Paul.   

Abstract

Studies of the ontogeny of the immune response to B512 dextran (Dex) show that antibody responses equal to those of adult mice are not attained until 12 wk of age. We have examined the anti-Dex response after immunization with a thymus-dependent antigen isomaltohexaosyl-keyhole limpet hemocyanin (IM6-KLH) and have shown that the development of the cross-reacting anti-Dex response parallels the development of Lyb-5+ B cells. Adult levels of anti-Dex antibody after immunization with IM6-KLH are achieved in mice between 3 and 12 wk of age, a time when Lyb-5+ cells have reached adult levels. Neonatal mice, immunized at 1 d or 1 wk after birth, failed to produce a significant amount of anti-Dex antibodies, although they did produce IM6-specific antibodies after immunization with IM6-KLH. Data, which support the conclusion from these experiments that Lyb-5+ cells are required for an anti-polysaccharide response even when the immunizing antigen is thymus-dependent, include the failure of IM6-KLH to stimulate a normal anti-Dex response in mice with the xid defect and the direct demonstration in normal adult mice that elimination of Lyb-5+ cells from spleens of mice primed with IM6-KLH abolishes the ability of these cells to transfer an anti-Dex response. The data imply that the expressed B cell repertoire in adult animals is skewed such that the vast majority of B cells capable of responding to polysaccharide determinants are in the Lyb-5+ subset.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6185616      PMCID: PMC2186926          DOI: 10.1084/jem.157.2.657

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  19 in total

1.  X-linked genetic control of hapten-polysaccharide-mediated specific immune unresponsiveness in CBA/N mice.

Authors:  B Merchant; H Snippe; E F Lizzio; J K Inman
Journal:  J Immunol       Date:  1978-04       Impact factor: 5.422

2.  Antitrinitrophenyl (TNP) plaque assay. Primary response of Balb/c mice to soluble and particulate immunogen.

Authors:  M B Rittenberg; K L Pratt
Journal:  Proc Soc Exp Biol Med       Date:  1969-11

3.  Role of accessory cells in B cell activation. II. The interaction of B cells with accessory cells results in the exclusive activation of an Lyb5+ B cell subpopulation.

Authors:  H S Boswell; A Ahmed; I Scher; A Singer
Journal:  J Immunol       Date:  1980-09       Impact factor: 5.422

4.  Role of T lymphocytes in the response to TNP-AECM-Ficoll.

Authors:  J J Mond; P K Mongini; D Sieckmann; W E Paul
Journal:  J Immunol       Date:  1980-09       Impact factor: 5.422

5.  Antibody affinity in mice with the CBA/N defect.

Authors:  K E Stein; C A Brennan; J J Mond; O Mäkelä; W E Paul
Journal:  J Immunol       Date:  1980-04       Impact factor: 5.422

6.  CBA/N X BALB/cJ F1 male and female mice can be primed to express quantitatively equivalent secondary anti-phosphocholine responses.

Authors:  E R Clough; D A Levy; J J Cebra
Journal:  J Immunol       Date:  1981-01       Impact factor: 5.422

7.  Characteristics of the T-dependent alpha(1 leads to 6) glucosyl (dextran) antibody response induced in mice with isomaltohexaose coupled to chicken gamma-globulin.

Authors:  C Moreno; C Hale; R Hewett; D Cussell
Journal:  Eur J Immunol       Date:  1979-11       Impact factor: 5.532

8.  Induction of B cell priming by neonatal injection of mice with thymic-independent (type 2) antigens.

Authors:  D E Mosier
Journal:  J Immunol       Date:  1978-10       Impact factor: 5.422

9.  Demonstration of phosphorylcholine-specific IgE B cells in CBA/N mice.

Authors:  T Kishimoto; S Shigemoto; T Watanabe; Y Yamamura
Journal:  J Immunol       Date:  1979-09       Impact factor: 5.422

10.  Inability of mice with a defect in B-lymphocyte maturation to respond to phosphorycholine on immunogenic carriers.

Authors:  J J Mond; R Lieberman; J K Inman; D E Mosier; W E Paul
Journal:  J Exp Med       Date:  1977-10-01       Impact factor: 14.307

View more
  11 in total

1.  Isotype profiles of anti-influenza antibodies in mice bearing the xid defect.

Authors:  M A Reale; C A Bona; J L Schulman
Journal:  J Virol       Date:  1985-02       Impact factor: 5.103

2.  Characterization of the immunodeficiency of RIIIS/J mice: immune response to polysaccharide antigens.

Authors:  J R Hiernaux; P J Baker; S J McEvoy; P W Stashak; M B Fauntleroy; E A Goidl
Journal:  Infect Immun       Date:  1990-05       Impact factor: 3.441

3.  Murine immune response to Neisseria meningitidis group C capsular polysaccharide: analysis of monoclonal antibodies generated in response to a thymus-independent antigen and a thymus-dependent toxoid conjugate vaccine.

Authors:  P A García-Ojeda; M E Monser; L J Rubinstein; H J Jennings; K E Stein
Journal:  Infect Immun       Date:  2000-01       Impact factor: 3.441

4.  Murine immune responses to Neisseria meningitidis group C capsular polysaccharide and a thymus-dependent toxoid conjugate vaccine.

Authors:  L J Rubinstein; P A García-Ojeda; F Michon; H J Jennings; K E Stein
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.441

5.  Surface plasmon resonance analysis of antipolysaccharide antibody specificity: responses to meningococcal group C conjugate vaccines and bacteria.

Authors:  Pablo A García-Ojeda; Sharon Hardy; Steven Kozlowski; Kathryn E Stein; Ian M Feavers
Journal:  Infect Immun       Date:  2004-06       Impact factor: 3.441

6.  Immunological evaluation of meningococcal group C polysaccharide-tetanus toxoid conjugate in mice.

Authors:  E C Beuvery; R W van Delft; F Miedema; V Kanhai; J Nagel
Journal:  Infect Immun       Date:  1983-08       Impact factor: 3.441

7.  Differential expression of sets of highly homologous variable region gene products in selected and preimmune repertoires of inbred mouse strains.

Authors:  D Primi; A M Drapier; P A Cazenave
Journal:  J Exp Med       Date:  1986-05-01       Impact factor: 14.307

8.  VH gene family expression in mice with the xid defect.

Authors:  S H Feng; K E Stein
Journal:  J Exp Med       Date:  1991-07-01       Impact factor: 14.307

9.  Neonatal administration of idiotype or antiidiotype primes for protection against Escherichia coli K13 infection in mice.

Authors:  K E Stein; T Söderström
Journal:  J Exp Med       Date:  1984-10-01       Impact factor: 14.307

10.  Oligosaccharide-protein conjugate vaccines induce and prime for oligoclonal IgG antibody responses to the Haemophilus influenzae b capsular polysaccharide in human infants.

Authors:  R A Insel; P W Anderson
Journal:  J Exp Med       Date:  1986-02-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.